Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,515 | -50,115 | -33,442 | -16,193 | -37,368 |
| Depreciation Amortization | 1,814 | 1,372 | 918 | 464 | 1,824 |
| Accounts receivable | 1,350 | 886 | 805 | 575 | 5,578 |
| Accounts payable and accrued liabilities | 3,455 | N/A | N/A | -2,469 | -4,335 |
| Other Working Capital | 2,526 | -523 | -1,752 | -2,341 | -5,894 |
| Other Operating Activity | 5,182 | 6,444 | 3,997 | 4,667 | 7,583 |
| Operating Cash Flow | $-56,188 | $-41,936 | $-29,474 | $-15,297 | $-32,612 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -254 | -131 | -128 | -111 | -769 |
| Investing Cash Flow | $-254 | $-131 | $-128 | $-111 | $-769 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 30,000 | 30,000 | N/A | 40,000 |
| Debt Repayment | -40,000 | -40,000 | -40,000 | N/A | N/A |
| Common Stock Issued | 23,753 | 21,206 | 21,212 | 20,259 | 18,429 |
| Other Financing Activity | -673 | -673 | -673 | 0 | 0 |
| Financing Cash Flow | $13,080 | $10,533 | $10,539 | $20,259 | $58,429 |
| Beginning Cash Position | 155,577 | 155,577 | 155,577 | 155,577 | 130,529 |
| End Cash Position | 112,215 | 124,043 | 136,514 | 160,428 | 155,577 |
| Net Cash Flow | $-43,362 | $-31,534 | $-19,063 | $4,851 | $25,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,188 | -41,936 | -29,474 | -15,297 | -32,612 |
| Capital Expenditure | -254 | -131 | -128 | -111 | -769 |
| Free Cash Flow | -56,442 | -42,067 | -29,602 | -15,408 | -33,381 |